BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6264317)

  • 1. Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation.
    Moss DJ; Rickinson AB; Wallace LE; Epstein MA
    Nature; 1981 Jun; 291(5817):664-6. PubMed ID: 6264317
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E; Masucci MG
    Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
    [No Abstract]   [Full Text] [Related]  

  • 3. Infection of mouse lymphocytes by Epstein-Barr virus. II. Stimulation of cellular DNA synthesis by EBV in the absence of EBNA induction and cell transformation.
    Gross TG; Volsky DJ
    Virology; 1984 Feb; 133(1):211-5. PubMed ID: 6322431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
    Ernberg I; Kallin B; Dillner J
    Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
    [No Abstract]   [Full Text] [Related]  

  • 5. EBV-activation of human B-lymphocytes.
    Aman P; Lewin N; Nordström M; Klein G
    Curr Top Microbiol Immunol; 1986; 132():266-71. PubMed ID: 3024919
    [No Abstract]   [Full Text] [Related]  

  • 6. The changing faces of EBV research.
    Klein G; Klein E
    Prog Med Virol; 1984; 30():87-106. PubMed ID: 6087416
    [No Abstract]   [Full Text] [Related]  

  • 7. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.
    Thorley-Lawson DA; Schooley RT; Bhan AK; Nadler LM
    Cell; 1982 Sep; 30(2):415-25. PubMed ID: 6291768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomes and cell surface markers of marmoset lymphocytes and Epstein-Barr virus-transformed marmoset cell lines.
    Johnson DR; Levan G; Klein G; Nigida SM; Wolfe LG
    Cancer Genet Cytogenet; 1981 Mar; 3(2):101-8. PubMed ID: 6268289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr viral DNA: infectivity for human placental cells.
    Miller G; Grogan E; Heston L; Robinson J; Smith D
    Science; 1981 Apr; 212(4493):452-5. PubMed ID: 6259735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV).
    Hu CP; Aman P; Masucci MG; Klein E; Klein G
    Eur J Immunol; 1986 Jul; 16(7):841-5. PubMed ID: 3013647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients.
    Tsoukas CD; Carson DA; Fong S; Slovin SF; Fox RI; Vaughan JH
    Clin Immunol Immunopathol; 1982 Jul; 24(1):8-14. PubMed ID: 6179673
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study of Epstein-Barr virus susceptibility in human tonsil B lymphocyte subpopulations].
    Harabuchi Y; Yamanaka N
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Nov; 90(11):1799-811. PubMed ID: 2833594
    [No Abstract]   [Full Text] [Related]  

  • 15. Regions of the EBV genome involved in latency and lymphocyte immortalization.
    Miller G
    Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
    [No Abstract]   [Full Text] [Related]  

  • 16. Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome.
    Mark W; Sugden B
    Virology; 1982 Oct; 122(2):431-43. PubMed ID: 6293180
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus terminal protein gene transcription is dependent on EBNA2 expression and provides evidence for viral integration into the host genome.
    Zimber-Strobl U; Suentzenich K; Falk M; Laux G; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
    Curr Top Microbiol Immunol; 1990; 166():359-66. PubMed ID: 1963585
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus and rheumatoid arthritis.
    Bluestein HG; Hasler F
    Surv Immunol Res; 1984; 3(1):70-7. PubMed ID: 6326237
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M; Lundgren E
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation.
    Bejarano MT; Masucci MG; Morgan A; Morein B; Klein G; Klein E
    J Virol; 1990 Mar; 64(3):1398-401. PubMed ID: 2154620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.